[1]Monti G, Herrera M, Kindge-Milles D, et al. The dose response multicenter international collaborative initiative (DO-RE-MI) [J]. Contrib Nephrol, 2007, 156(2): 434-443.
[2]Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: a prospective randomized trial[J]. Lancet, 2000, 356(9223): 26-30.
[3]陈香美. 血液净化标准操作规程2010版[M]. 北京:人民军医出版社,2010:85-86.
[4]Tan HK, Baldwin I, Bellomo R. Continuous venovenous hemofiltration without anticoagu- lation in high-risk patients[J]. Intensive Care Med, 2000,26(11):1652-1657.
[5]Nagarik AP, Soni SS, Adikey GK, et al. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy[J]. Saudi J Kidney Dis Transpl, 2010,21(3):478-483.
[6]Ramesh Prasad GV, Palevsky PM, Burr R, et al. Factors affecting system clotting in continuous renal replacement therapy: results of a randomized, controlled trial[J]. Clin Nephrol, 2000, 53(1):55-60.
[7]Sagedal S, Hartmann A, Osnes K, et al. Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin[J]. Nephrol Dial Transplant, 2006,21(2):444-449.
[8]曹丽霞,李晶晶,董 娟,等. 危重症患者行床旁连续性血液净化治疗的护理风险管理探讨[J]. 东南国防医药, 2015,17(1):87-89.
[9]陈吕静,许 丽,许晓惠. 流程管理在肾科ICU行床旁连续性血液净化患者中的应用[J]. 东南国防医药,2014,16(1):91-92.
[10]Khwaja A.KDIGO clinical practice guideline for acute kidney injury[J]. Nephron Clin Pract,2012,120(4):179-184.
[1]艾燕,周虹.原发性淀粉样变性患者行自体外周血干细胞移植并发急性肾损伤的护理[J].医学研究与战创伤救治(原医学研究生学报),2016,18(02):201.[doi:10.3969/j.issn.1672-271X.2016.02.031]
[2]王燕.高风险高龄心房颤动患者抗凝与联合抗栓疗效及安全性比较[J].医学研究与战创伤救治(原医学研究生学报),2017,19(05):522.[doi:10.3969/j.issn.1672-271X.2017.05.019]
[3]项龙,任宏,奚悦玲,等.局部枸橼酸抗凝技术在儿童连续肾脏替代治疗中的临床应用[J].医学研究与战创伤救治(原医学研究生学报),2018,20(05):459.[doi:10.3969/j.issn.1672-271X.2018.05.003]
XIANG Long,REN Hong,XI Yue-ling,et al.Clinical application of regional citrate anticoagulation in pediatrics continuous renal replacement therapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(01):459.[doi:10.3969/j.issn.1672-271X.2018.05.003]
[4]李丹丹,庄微,宫剑滨.单中心非瓣膜性心房颤动患者抗凝治疗的现状分析[J].医学研究与战创伤救治(原医学研究生学报),2021,23(04):363.[doi:10.3969/j.issn.1672-271X.2021.04.006]
LI Dan-dan,ZHUANG Wei,GONG Jian-bin.Analyze the status of anticoagulant therapy in patients with nonvalvular atrial fibrillation[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(01):363.[doi:10.3969/j.issn.1672-271X.2021.04.006]
[5]周楚瑶,薛 凡.阿加曲班在连续性肾脏替代治疗中的疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2013,15(06):594.[doi:10.3969/j.issn.1672-271X.2013.06.013]
ZHOU Chu-yao,XUE Fan..Clinical observation of argatroban in continuous renal replacement therapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(01):594.[doi:10.3969/j.issn.1672-271X.2013.06.013]